7/2, 6:54 PM (Source: TeleTrader)
more TeleTrader news

Inovio surges over 9% on positive vaccine results

Shares of Inovio Pharmaceuticals Inc. jumped more than 9% on Thursday after the company revealed plans to start nationwide trials of its COVID-19 vaccine during July.

Commenting on the progress, Inovio's Chief Executive Joseph Kim recently said the company "demonstrated the vaccine is safe. It also found the vaccine is immunogenic, meaning immune responses that can potentially be protective against the COVID-19 virus could be seen." Meanwhile, President Donald Trump also spoke positively about the vaccine candidates, likely relating to the Inovio's current progress.

Inovio's stocks soared 9.01% to sell for $21.53 per share at 12:52 pm ET.

Breaking the News / ND